rediff News http://www.rediff.com/tags/novartis+ag India's largest news and entertainment service online.. en-us Wed, 30 Jul 14 21:39:00 +0000 Wed, 30 Jul 14 21:39:00 +0000 http://www.rediff.com/push Rediff feeds Copyright: (C) 2009 Rediff.com India Limited. All Rights Reserved. <![CDATA[Govt refutes Novartis' allegations on patents]]> http://www.rediff.com/money/report/govt-refutes-novartis-allegations-on-patents/20130828.htm Thu, 31 Jul 2014 03:09:00 +0530 <![CDATA[US sues Novartis, alleging kickbacks to pharmacies]]> http://www.rediff.com/money/report/us-sues-novartis-alleging-kickbacks-to-pharmacies/20130425.htm Thu, 31 Jul 2014 03:09:00 +0530 <![CDATA['Novartis case: SC ruling wise and balanced']]> http://www.rediff.com/money/interview/interview-novartis-ruling-is-not-an-anti-patent-judgement/20130410.htm Thu, 31 Jul 2014 03:09:00 +0530 <![CDATA[SC decision on Novartis "historic": Anand Sharma]]> http://www.rediff.com/money/report/sc-decision-on-novartis-historic-anand-sharma1/20130401.htm Thu, 31 Jul 2014 03:09:00 +0530 <![CDATA[SC denies patent to Novartis's cancer drug Glivec]]> http://www.rediff.com/money/report/sc-dismisses-novartis-petition-for-glivec-patent/20130401.htm Thu, 31 Jul 2014 03:09:00 +0530 <![CDATA[ Key Vendors are Bayer, F. Hoffmann-La Roche, Novartis and Regeneron Pharmaceuticals]]> http://in.sys-con.com/node/3130434 Thu, 31 Jul 2014 03:09:00 +0530 <![CDATA[Ranbaxy posts loss on provision for U.S. settlement]]> https://in.news.yahoo.com/ranbaxy-laboratories-posts-loss-june-quarter-112922155--finance.html Thu, 31 Jul 2014 03:09:00 +0530 <![CDATA[Novartis vaccine Bexsero® sees high uptake in first large-scale public vaccination program to help protect against devastating meningitis B]]> http://andhranews.net/Business/2014/Novartis-vaccine-Bexsero-sees-uptake-first-32721.htm Thu, 31 Jul 2014 03:09:00 +0530 <![CDATA[BRIC Dominate In Vitro Diagnostic Market (IVD) Global Growth Forecasts to 2017]]> http://in.advfn.com/p.php?pid=nmona&article=63054027 Thu, 31 Jul 2014 03:09:00 +0530 <![CDATA[Alcon's Simbrinza® approved in the EU to treat patients living with glaucoma, a chronic sight-threatening eye disease]]> http://andhranews.net/Business/2014/Alconaposs-Simbrinza-approved-EU-treat-patients-32673.htm Thu, 31 Jul 2014 03:09:00 +0530